Bim is a Suppressor of Myc-induced Mouse B Cell Leukemia

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Apr 14

PMID 15079075

Citations 256

Authors

Alexander Egle

Alan W Harris

Philippe Bouillet

Suzanne Cory

Affiliations

Soon will be listed here.

Abstract

Impaired apoptosis is now recognized to be central to tumor development. Bcl2, activated by chromosomal translocation in human follicular lymphoma, promotes oncogenesis by inhibiting apoptosis. Bim, a distant proapoptotic relative, is emerging as a major physiologic antagonist of Bcl2. Here, we show that loss of Bim is oncogenic. Bim protein levels were elevated in the apoptosis-prone B lymphoid cells of Emicro-Myc-transgenic mice, and Bim-mutant Emicro-Myc mice had increased numbers of IgM-bearing B cells. Emicro-Myc-expressing B lymphoid cells deficient in Bim were refractory to apoptosis induced in vitro by cytokine deprivation or antigen receptor cross-linking. Thus, Bim is induced by Myc in B cells and mediates apoptosis. Remarkably, inactivation of even a single allele of Bim accelerated Myc-induced development of tumors, particularly acute B cell leukemia. None of the primary tumors from Bim(+/-) Emicro-Myc mice displayed loss of the second allele of Bim. These findings indicate that Bim is a tumor suppressor, at least in B lymphocytes, and is haploinsufficient. Whereas the p19Arf/p53 pathway is frequently mutated in tumors arising in Bim(+/+) Emicro-Myc mice, it was unaffected in most Bim-deficient tumors, indicating that Bim reduction is an effective alternative to loss of p53 function.

Citing Articles

Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening.

Jin W, Deng Y, La Marca J, Lelliott E, Diepstraten S, Konig C Nat Commun. 2025; 16(1):974.

PMID: 39885149 PMC: 11782673. DOI: 10.1038/s41467-025-56282-2.

The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies.

Yu M, Nah G, Krishnan V, Sulaimi F, Ng K, Wang C Leukemia. 2024; 39(1):134-143.

PMID: 39438588 DOI: 10.1038/s41375-024-02418-0.

Antioxidant Defenses, Oxidative Stress Responses, and Apoptosis Modulation in Spontaneous Abortion: An Immunohistochemistry Analysis of First-Trimester Chorionic Villi.

Vornic I, Nesiu A, Ardelean A, Todut O, Pasare V, Onel C Life (Basel). 2024; 14(9).

PMID: 39337859 PMC: 11432807. DOI: 10.3390/life14091074.

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.

Bristol J, Nelson S, Ohashi M, Casco A, Hayes M, Ranheim E PLoS Pathog. 2024; 20(4):e1012132.

PMID: 38620028 PMC: 11045125. DOI: 10.1371/journal.ppat.1012132.

Apoptotic cell death in disease-Current understanding of the NCCD 2023.

Vitale I, Pietrocola F, Guilbaud E, Aaronson S, Abrams J, Adam D Cell Death Differ. 2023; 30(5):1097-1154.

PMID: 37100955 PMC: 10130819. DOI: 10.1038/s41418-023-01153-w.

References

Adams J, Harris A, Pinkert C, Corcoran L, Alexander W, Cory S . The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985; 318(6046):533-8. DOI: 10.1038/318533a0. View

Bouillet P, Metcalf D, Huang D, Tarlinton D, Kay T, Kontgen F . Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 1999; 286(5445):1735-8. DOI: 10.1126/science.286.5445.1735. View

Harris A, Pinkert C, Crawford M, Langdon W, Brinster R, Adams J . The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J Exp Med. 1988; 167(2):353-71. PMC: 2188841. DOI: 10.1084/jem.167.2.353. View

Vaux D, Cory S, Adams J . Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988; 335(6189):440-2. DOI: 10.1038/335440a0. View

Strasser A, Harris A, Bath M, Cory S . Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 1990; 348(6299):331-3. DOI: 10.1038/348331a0. View

McDonnell T, Korsmeyer S . Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature. 1991; 349(6306):254-6. DOI: 10.1038/349254a0. View

Askew D, Ashmun R, Simmons B, Cleveland J . Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 1991; 6(10):1915-22. View

Evan G, Wyllie A, GILBERT C, Littlewood T, Land H, Brooks M . Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992; 69(1):119-28. DOI: 10.1016/0092-8674(92)90123-t. View

Strasser A, Harris A, Cory S . E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene. 1993; 8(1):1-9. View

10.

Bouillet P, Zhang L, Huang D, Webb G, Bottema C, Shore P . Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome. 2001; 12(2):163-8. DOI: 10.1007/s003350010242. View

11.

Zhou P, Levy N, Xie H, Qian L, Lee C, Gascoyne R . MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood. 2001; 97(12):3902-9. DOI: 10.1182/blood.v97.12.3902. View

12.

Eischen C, Woo D, Roussel M, Cleveland J . Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol. 2001; 21(15):5063-70. PMC: 87232. DOI: 10.1128/MCB.21.15.5063-5070.2001. View

13.

Nakano K, Vousden K . PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001; 7(3):683-94. DOI: 10.1016/s1097-2765(01)00214-3. View

14.

Puthalakath H, Villunger A, OReilly L, Beaumont J, Coultas L, Cheney R . Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science. 2001; 293(5536):1829-32. DOI: 10.1126/science.1062257. View

15.

Sherr C . The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol. 2001; 2(10):731-7. DOI: 10.1038/35096061. View

16.

Bouillet P, Cory S, Zhang L, Strasser A, Adams J . Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell. 2001; 1(5):645-53. DOI: 10.1016/s1534-5807(01)00083-1. View

17.

Bouillet P, Purton J, Godfrey D, Zhang L, Coultas L, Puthalakath H . BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 2002; 415(6874):922-6. DOI: 10.1038/415922a. View

18.

Rutledge S, Chin J, Schepartz A . A view to a kill: ligands for Bcl-2 family proteins. Curr Opin Chem Biol. 2002; 6(4):479-85. DOI: 10.1016/s1367-5931(02)00352-6. View

19.

Cory S, Adams J . The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002; 2(9):647-56. DOI: 10.1038/nrc883. View

20.

Baell J, Huang D . Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs. Biochem Pharmacol. 2002; 64(5-6):851-63. DOI: 10.1016/s0006-2952(02)01148-6. View